` LN5 (Lannett Company Inc) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

L
LN5
vs
NOVO B

Over the past 12 months, LN5 has underperformed NOVO B, delivering a return of 0% compared to the NOVO B's 54% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
LN5
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

L
LN5 Intrinsic Value
Not Available
NOVO B Intrinsic Value
635.32 DKK
Undervaluation 29%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
L
Lannett Company Inc
F:LN5
2.254 EUR
Novo Nordisk A/S
CSE:NOVO B
450.5 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
LN5 vs NOVO B

LN5
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
L
Lannett Company Inc
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
LN5 vs NOVO B

LN5
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
L
Lannett Company Inc
F:LN5
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

LN5
9.7%
NOVO B
84.3%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Lannett Company Inc
Novo Nordisk A/S

Operating Margin

LN5
-20.6%
NOVO B
44.6%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Lannett Company Inc
Novo Nordisk A/S

Net Margin

LN5
-68%
NOVO B
34.5%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Lannett Company Inc
Novo Nordisk A/S

FCF Margin

LN5
-5.2%
NOVO B
24.5%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Lannett Company Inc
Novo Nordisk A/S

ROE

LN5
0%
NOVO B
88.1%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Lannett Company Inc
Novo Nordisk A/S

ROA

LN5
0%
NOVO B
26.6%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Lannett Company Inc
Novo Nordisk A/S

ROIC

LN5
0%
NOVO B
30.4%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Lannett Company Inc
Novo Nordisk A/S

ROCE

LN5
0%
NOVO B
70%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Lannett Company Inc
Novo Nordisk A/S

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
LN5 vs NOVO B

Loading

Performance Gap
LN5 vs NOVO B

Loading
LN5
NOVO B
Difference
www.alphaspread.com

Performance By Year
LN5 vs NOVO B

Loading
LN5
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare LN5 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account